Research - Jena, Thuringia, Germany
Axenoll® is a technology company that develops and industrialises projects, ranging from a development task to industrial production on a very large scale. The company owns the global licencing rights for cellular and molecular 3D bioprinting in the context of clean room research & development, production and marketing based on the patented Exentis 3D Mass Customization®, the 3D screen printing technology made available by Exentis. Axenoll® is revolutionising 3D bioprinting through "Axenoll® 3D printing for life".
Varnish
Amazon AWS
Mobile Friendly